an innovator in surgical adhesion prevention devices, today announced its planned participation in key medical and investor conferences throughout the first half of 2025. These events will provide ...
AstraZeneca’s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...
Eyes with vitreomacular adhesion-related disorders can experience ... A brief overview of vitreoretinal surgery is discussed, as well as agents that have been evaluated for pharmacologic vitreolysis.
Brain Scan Predicts Effectiveness of Spinal Cord Surgery Dec. 3, 2024 — A 10-minute brain scan can predict the effectiveness of a risky spinal surgery to alleviate intractable pain. The result ...